A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

Milam Brantley Jr., M.D., Ph.D., associate professor of Ophthalmology and Visual Sciences and Molecular Physiology and Biophysics, recently received a $500,000 grant from the Edward N. and Della L. Thome Memorial Foundation Awards Program in Macular Degeneration Research to further his work on age-related macular degeneration (AMD).

Colleagues of Vivien Casagrande, Ph.D., celebrated her distinguished career in the visual sciences with a “Lifetime of Vision” symposium Nov. 18 in Biological Sciences/Medical Research Building III.

With the end of daylight saving time, ophthalmologists at the Vanderbilt Eye Institute want to focus on a real issue—dim-light driving situations that can endanger drivers and pedestrians.

Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina.

Sean Donahue, M.D., Ph.D., Sam and Darthea Coleman Professor of Pediatric Ophthalmology at Vanderbilt University Medical Center (VUMC), was recently named a Choosing Wisely Champion by the American Association for Pediatric Ophthalmology and Strabismus (AAPOS).

Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.